"Lymphatic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.
Below are MeSH descriptors whose meaning is more general than "Lymphatic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Lymphatic Diseases".
This graph shows the total number of publications written about "Lymphatic Diseases" by people in this website by year, and whether "Lymphatic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Lymphatic Diseases" by people in Profiles.
Risks and contraindications of medical compression treatment - A critical reappraisal. An international consensus statement. Phlebology. 2020 Aug; 35(7):447-460.
Superselective retrograde lymphatic duct embolization for management of postoperative lymphatic leak. Diagn Interv Radiol. 2017 Sep-Oct; 23(5):379-380.
Net-like superficial vascular malformation: clinical description and evidence for lymphatic origin. Br J Dermatol. 2016 Jul; 175(1):191-3.
Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? Eur Radiol. 2015 Feb; 25(2):480-7.
The dark lymph node sign on magnetic resonance imaging: a novel finding in patients with sarcoidosis. J Thorac Imaging. 2014 Mar; 29(2):125-9.
Bacteria activate sensory neurons that modulate pain and inflammation. Nature. 2013 Sep 05; 501(7465):52-7.
Diverse manifestations and management options in Klippel-Trenaunay syndrome: a single centre 10-year experience. J Plast Surg Hand Surg. 2013 Sep; 47(4):303-7.
A subset of Rosai-Dorfman disease exhibits features of IgG4-related disease. Am J Clin Pathol. 2013 May; 139(5):622-32.
Referrals for suspected hematologic malignancy: a survey of primary care physicians. Am J Hematol. 2012 Jun; 87(6):634-6.
Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial. Eur Heart J. 2010 Feb; 31(4):480-8.